Mette Nyegaard

Dr. Mette Nyegaard


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JGJakob Grove
Jakob Grove
SRStephan Ripke
Stephan Ripke
TAThomas D. Als
Thomas D. Als
MMManuel Mattheisen
Manuel Mattheisen
RWRaymond K. Walters
Raymond K. Walters
BUBupgen
Bupgen
Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants contribute substantially to ASD susceptibility, but to date no individual variants have been robustly associated with ASD. With a marked sample-size increase from a unique Danish population resource, we report a genome-wide association meta-analysis of 18,381 individuals with ASD and 27,969 controls that identified five genome-wide-significant loci. Leveraging GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), we identified seven additional loci shared with other traits at equally strict significance levels. Dissecting the polygenic architecture, we found both quantitative and qualitative polygenic heterogeneity across ASD subtypes. These results highlight biological insights, particularly relating to neuronal function and corticogenesis, and establish that GWAS performed at scale will be much more productive in the near term in ASD.

1 July 2009 in Nature
Verified
Journal Article
Closed access
PDF file
†(†Genetic Risk and Outcome in Psychosis (GROUP)
†Genetic Risk and Outcome in Psychosis (GROUP)
HSHreinn Stefansson
Hreinn Stefansson
RORoel A. Ophoff
Roel A. Ophoff
SSStacy Steinberg
Stacy Steinberg
OAOle A. Andreassen
Ole A. Andreassen
DCDavid A. Collier
David A. Collier

1 August 2007 in Endocrinology
Verified
Journal Article
Closed access
RBRichard O. Burney
Richard O. Burney
STSaid Talbi
Said Talbi
AHAmy E. Hamilton
Amy E. Hamilton
KVKim Chi Vo
Kim Chi Vo
MNMette Nyegaard
Mette Nyegaard
LGLinda C. Giudice
Linda C. Giudice
The identification of molecular differences in the endometrium of women with endometriosis is an important step toward understanding the pathogenesis of this condition and toward developing novel strategies for the treatment of associated infertility and pain. In this study, we conducted global gene expression analysis of endometrium from women with and without moderate/severe stage endometriosis and compared the gene expression signatures across various phases of the menstrual cycle. The transcriptome analysis revealed molecular dysregulation of the proliferative-to-secretory transition in endometrium of women with endometriosis. Paralleled gene expression analysis of endometrial specimens obtained during the early secretory phase demonstrated a signature of enhanced cellular survival and persistent expression of genes involved in DNA synthesis and cellular mitosis in the setting of endometriosis. Comparative gene expression analysis of progesterone-regulated genes in secretory phase endometrium confirmed the observation of attenuated progesterone response. Additionally, interesting candidate susceptibility genes were identified that may be associated with this disorder, including FOXO1A, MIG6, and CYP26A1. Collectively these findings provide a framework for further investigations on causality and mechanisms underlying attenuated progesterone response in endometrium of women with endometriosis.

25 May 2020 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
HZHang Zhou
Hang Zhou
JSJulia M. Sealock
Julia M. Sealock
SSSandra Sanchez-Roige
Sandra Sanchez-Roige
TCToni-Kim Clarke
Toni-Kim Clarke
DLDaniel Levey
Daniel Levey
JGJoel Gelernter
Joel Gelernter

1 October 2012 in The American Journal of Human Genetics
Verified
Journal Article
Open access
MNMette Nyegaard
Mette Nyegaard
MOMichael T. Overgaard
Michael T. Overgaard
MSMads T. Søndergaard
Mads T. Søndergaard
MVMarta Vranas
Marta Vranas
EBElijah R. Behr
Elijah R. Behr
ABAnders D. Børglum
Anders D. Børglum
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a devastating inherited disorder characterized by episodic syncope and/or sudden cardiac arrest during exercise or acute emotion in individuals without structural cardiac abnormalities. Although rare, CPVT is suspected to cause a substantial part of sudden cardiac deaths in young individuals. Mutations in RYR2, encoding the cardiac sarcoplasmic calcium channel, have been identified as causative in approximately half of all dominantly inherited CPVT cases. Applying a genome-wide linkage analysis in a large Swedish family with a severe dominantly inherited form of CPVT-like arrhythmias, we mapped the disease locus to chromosome 14q31-32. Sequencing CALM1 encoding calmodulin revealed a heterozygous missense mutation (c.161A>T [p.Asn53Ile]) segregating with the disease. A second, de novo, missense mutation (c.293A>G [p.Asn97Ser]) was subsequently identified in an individual of Iraqi origin; this individual was diagnosed with CPVT from a screening of 61 arrhythmia samples with no identified RYR2 mutations. Both CALM1 substitutions demonstrated compromised calcium binding, and p.Asn97Ser displayed an aberrant interaction with the RYR2 calmodulin-binding-domain peptide at low calcium concentrations. We conclude that calmodulin mutations can cause severe cardiac arrhythmia and that the calmodulin genes are candidates for genetic screening of individual cases and families with idiopathic ventricular tachycardia and unexplained sudden cardiac death.

13 March 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NRNilufer Rahmioglu
Nilufer Rahmioglu
SMSally Mortlock
Sally Mortlock
MGMarzieh Ghiasi
Marzieh Ghiasi
PMPeter L Møller
Peter L Møller
LSLilja Stefansdottir
Lilja Stefansdottir
KZKrina Zondervan
Krina Zondervan